{
  "id": "d8cc0440e17ade82",
  "title": "STAT+: Pharmalittle: We\u2019re reading about an FDA official\u2019s speech, a Grail cancer blood test, and much more",
  "description": "The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV",
  "content": "The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/20/fda-cancer-antibiotics-kickbacks-otc-patents-covid/?utm_campaign=rss",
  "published_at": "2026-02-20T14:26:16+00:00",
  "fetched_at": "2026-02-21T00:28:01.720640+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about an FDA official\u2019s speech, a Grail cancer blood test, and much more",
    "description": "The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV",
    "url": "https://www.statnews.com/pharmalot/2026/02/20/fda-cancer-antibiotics-kickbacks-otc-patents-covid/?utm_campaign=rss",
    "published": "2026-02-20T14:26:16+00:00",
    "source": "STAT"
  }
}